First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

1. Martínez-Calle, N.
2. Alfonso, A.
3. Rifón, J.
4. Herrero, I.
5. Errasti, P.
6. Rábago, G.
7. Merino, J.
8. Panizo, Á.
9. Pardo, J.
10. Prósper, F.
11. García-Muñoz, R.
12. Lecumberri, R.
13. Panizo, C.